Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REPAGLINIDE vs REVLIMID: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REPAGLINIDE vs REVLIMID: Safety Overview

Metric REPAGLINIDE REVLIMID
Total FAERS Reports 2,544 8,878
Deaths Reported 169 1,233
Death Rate 6.6% 13.9%
Hospitalizations 1,517 3,659
Average Patient Age 71.9 yrs 69.5 yrs
% Female Patients 45.5% N/A
FDA Approval Date Apr 24, 2015 N/A
Manufacturer Rising Pharma Holdings, Inc. N/A
Route ORAL N/A
Marketing Status Discontinued N/A